Results 151 to 160 of about 7,018 (165)

Aberrant expression of HMB45 and negative PRAME expression in halo nevi

Journal of Cutaneous Pathology, 2021
Kristen N Ruby, Shaofeng Yan, Zhongze Li
exaly  

Immunohistochemical Profiling of Conjunctival Melanocytic Intraepithelial Lesions, Including SOX10, HMB45, Ki67, and P16

American Journal of Ophthalmology, 2021
David Elder, Kareem Sioufi, Carol Shields   +2 more
exaly  

Expression of the B-Cell Proliferation Marker MUM1 by Melanocytic Lesions and Comparison with S100, gp100 (HMB45), and MelanA

Modern Pathology, 2003
Yasodha Natkunam, Robert V Rouse
exaly  

A p16-Ki-67-HMB45 immunohistochemistry scoring system as an ancillary diagnostic tool in the diagnosis of melanoma

Diagnostic Pathology, 2015
Matthieu Talagas, Arnaud Uguen, Pascale Marcorelles   +2 more
exaly  

HMB45 Negative Spindle Cell Malignant Melanoma

American Journal of Dermatopathology, 1997
Henry G Skelton, J H Graham, Kathleen J Smith   +2 more
exaly  

Gastrointestinal stromal tumours can express CD10 and epithelial membrane antigen but not oestrogen receptor or HMB45

Histopathology, 2011
Zsombor Melegh, Newton A C S Wong
exaly  

Specificity of tyrosinase and HMB45 PCR in the detection of melanoma metastases in sentinel lymph node biopsies

Histopathology, 2002
Ralf Gutzmer, Alexander Kapp, B Volker
exaly  

Cystic pulmonary metastases of endometrial stromal sarcoma of the uterus, mimicking lymphangiomyomatosis: A case report with immunohistochemistry of HMB45

Pathology International, 1997
M Fukayama
exaly  

Immunoprofile of MITF, Tyrosinase, Melan-A, and MAGE-1 in HMB45-Negative Melanomas

American Journal of Surgical Pathology, 2002
David Elder
exaly  

Nuclear to non-nuclear Pmel17/gp100 expression (HMB45 staining) as a discriminator between benign and malignant melanocytic lesions

Modern Pathology, 2008
David Elder, David L Rimm, Ruth Halaban
exaly